tiprankstipranks
Advertisement
Advertisement
Enlivex Doses First U.S. Patient in Phase 2b Allocetra Trial for Knee Osteoarthritis
PremiumCompany AnnouncementsEnlivex Doses First U.S. Patient in Phase 2b Allocetra Trial for Knee Osteoarthritis
27d ago
Enlivex Therapeutics doses first patient in Allocetra trial
Premium
The Fly
Enlivex Therapeutics doses first patient in Allocetra trial
27d ago
Enlivex Faces Nasdaq Minimum Bid Price Deficiency After Shares Fall Below $1 Threshold
Premium
Company Announcements
Enlivex Faces Nasdaq Minimum Bid Price Deficiency After Shares Fall Below $1 Threshold
29d ago
Enlivex Shares Tokenized on Ondo Global Markets to Expand Global Digital Investor Access
PremiumCompany AnnouncementsEnlivex Shares Tokenized on Ondo Global Markets to Expand Global Digital Investor Access
2M ago
Enlivex Therapeutics price target raised to $20 from $13 at H.C. Wainwright
Premium
The Fly
Enlivex Therapeutics price target raised to $20 from $13 at H.C. Wainwright
2M ago
Enlivex Highlights Rain’s AI Agent Launch and $5 Million Grant Program to Expand Prediction Markets
Premium
Company Announcements
Enlivex Highlights Rain’s AI Agent Launch and $5 Million Grant Program to Expand Prediction Markets
3M ago
Enlivex Therapeutics announces FDA clearance of Allocetra new drug application
PremiumThe FlyEnlivex Therapeutics announces FDA clearance of Allocetra new drug application
3M ago
Enlivex Rebrands as Enlivex Ltd. Following Shareholder Approval
Premium
Company Announcements
Enlivex Rebrands as Enlivex Ltd. Following Shareholder Approval
4M ago
Enlivex Therapeutics management to meet virtually with BTIG
Premium
The Fly
Enlivex Therapeutics management to meet virtually with BTIG
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100